SPONSOR

Peking Union Medical College Hospital

Total Trials

Recruiting

Phases

Phase 2, Phase 3, Phase 2, Phase 4, EARLY_Phase 1, Phase 1, Phase 2, Phase 1

Conditions studied: Coronary Artery Disease Coronary Artery Stenosis Coronary Artery Restenosis Coronary Artery Disease Progression Inflammation Inflammatory Disease Inflammation Vascular Locally Advanced Esophageal Squamous Cell Carcinoma Endometrial Cancer Malignant Neoplasms of Brain

Peking Union Medical College Hospital is a clinical research sponsor with 37 registered studies on ClinicalTrials.gov, of which 37 are actively recruiting participants. Research covers conditions including Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis, Coronary Artery Disease Progression.

The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Peking Union Medical College Hospital

How many clinical trials has Peking Union Medical College Hospital sponsored?

ClinicalMetric currently tracks 37 clinical trials sponsored by Peking Union Medical College Hospital, of which 37 are actively recruiting participants. These trials cover conditions including Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Peking Union Medical College Hospital research focus on?

Peking Union Medical College Hospital clinical trials span Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis, Coronary Artery Disease Progression, Inflammation, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Peking Union Medical College Hospital clinical trial?

To participate in a Peking Union Medical College Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking Union Medical College Hospital trials with current recruitment status updated daily.

Peking Union Medical College Hospital

Frequently Asked Questions — Peking Union Medical College Hospital

Clinical Trials by Peking Union Medical College Hospital

Disease Characteristics of IR-CAD: a Case-control Study

Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma

Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors

Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors

Serplulimab Combined With CCRT for LS-SCLC.

The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic Amenorrhea

Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI

Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients

Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

Perioperative Statins to Prevent AFib After Lung Surgery

Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7

Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study

Modified Tumor-free Techniques Operation to Cervical Cancer

Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade

Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD

National Registry of IRPF in China

A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks

AI Detection of Bladder Tumors Under Endoscopy

Teclistamab in Previously Treated AL Amyloidosis

AI in Predicting Polyp Pathology and Endoscopic Classification

Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia

Al18F-NOTA-LM3 PET/CT in Patients With TIO

Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation

PEEP Titration and Lung Recruitment Potential Assessed by 3D EIT

A Prospective Cohort Study of IgG4RD in China